skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: AUC Wiley Frozen Package in 2012 remover assunto: Science & Technology remover IngentaConnect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Review article: the design of clinical trials in hepatic encephalopathy – an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement
Review article: the design of clinical trials in hepatic encephalopathy – an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement
Material Type:
Artigo 		Adicionar ao Meu Espaço

Review article: the design of clinical trials in hepatic encephalopathy – an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement

Bajaj, J. S. ; Cordoba, J. ; Mullen, K. D. ; Amodio, P. ; Shawcross, D. L. ; Butterworth, R. F. ; Morgan, M. Y.

Alimentary pharmacology & therapeutics, 2011-04, Vol.33 (7), p.739-747 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
2
S2′‐subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor ‐2 domain1‐wild‐type, Leu17Arg‐mutant and aprotinin
S2′‐subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor ‐2 domain1‐wild‐type, Leu17Arg‐mutant and aprotinin
Material Type:
Artigo 		Adicionar ao Meu Espaço

S2′‐subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor ‐2 domain1‐wild‐type, Leu17Arg‐mutant and aprotinin

Vadivel, K. ; Kumar, Y. ; Ogueli, G. I. ; Ponnuraj, S. M. ; Wongkongkathep, P. ; Loo, J. A. ; Bajaj, M. S. ; Bajaj, S. P.

Journal of thrombosis and haemostasis, 2016-12, Vol.14 (12), p.2509-2523 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Beta‐blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation
Beta‐blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Beta‐blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation

Bhutta, A. Q. ; Garcia‐Tsao, G. ; Reddy, K. R. ; Tandon, P. ; Wong, F. ; O'Leary, J. G. ; Acharya, C. ; Banerjee, D. ; Abraldes, J. G. ; Jones, T. M. ; Shaw, J. ; Deng, Y. ; Ciarleglio, M. ; Bajaj, J. S.

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.78-85 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.